VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1010646
Sex: U
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: testing positive for COVID; Test Result: Positive

Allergies:

Symptoms: testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 1st of 14 reports. An elderly patient (more than 65 years old) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021 with outcome of unknown. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab (drug being administered under FDA EUA). The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021065206 same reporter/drug/event, different patient.;US-PFIZER INC-2021065202 same reporter/drug/event, different patient.;US-PFIZER INC-2021065199 same reporter/drug/event, different patient.;US-PFIZER INC-2021065208 same reporter/drug/event, different patient.;US-PFIZER INC-2021065203 same reporter/drug/event, different patient.;US-PFIZER INC-2021065200 same reporter/drug/event, different patient.;US-PFIZER INC-2021065205 same reporter/drug/event, different patient.;US-PFIZER INC-2021065210 same reporter/drug/event, different patient.;US-PFIZER INC-2021065201 same reporter/drug/event, different patient.;US-PFIZER INC-2021065209 same reporter/drug/event, different patient.;US-PFIZER INC-2021065207 same reporter/drug/event, different patient.;US-PFIZER INC-2021065198 same reporter/drug/event, different patient.;US-PFIZER INC-2021065204 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 1010647
Sex: F
Age:
State: TX

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Fever; Result Unstructured Data: Test Result:100.3

Allergies:

Symptoms: Tired; Feel bad; Weak; Sore arm; Fever 100.3; This is a spontaneous report from a contactable consumer reported for herself. A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer; lot number: unknown; reason why batch/lot was unknown: misplaced/discarded) via an unspecified route of administration at left arm on 21Jan2021 09:45 AM at a single dose for COVID-19 immunization. Medical history included anxiety, high blood pressure (HBP). Since Covid - short of breath still racing heart. Allergies to medications, food, or other products included penicillin and apple juice. Prior to vaccination, the patient was diagnosed with COVID-19 (short of breath still racing heart). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination included niacin, lisinopril, venlafaxine and montluskat for allergy. Facility where the most recent COVID-19 vaccine was administered was at public health clinic/veterans administration facility. The patient was not pregnant at the time of vaccination. The patient experienced adverse events included tired, feel bad/weak, sore arm, fever 100.3; with start date on 22Jan2021 at 03:00 PM. The events were reported as non-serious. The outcome of events was resolving. Treatment Tylenol received for fever. Since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds: NIACIN; LISINOPRIL; VENLAFAXINE; MONTELUKAST

Current Illness:

ID: 1010648
Sex: F
Age:
State: NY

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sleeplessness; Diarrhea; Nausea; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer (patient): A 39-year-old female patient received the 1st doe of bnt162b2 (BNT162B2, batch/lot is unknown misplaced/discarded) at single dose at right arm on 21Jan2021 19:00 for covid-19 immunisation, administered at hospital Medical history included ankylosing spondylitis, uveitis, coeliac disease, postural orthostatic tachycardia syndrome (POTS), food allergy, mycotic allergy. Allergies: Coconut, ASPIRIN, REGLAN, mold. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included: atenolol (manufacturer unknown), cetirizine hydrochloride (ZYRTEC), infliximab (REMICADE). The patient received no other vaccines within 4 weeks prior to the COVID vaccine. On 22Jan2021 12:00 AM the patient experienced sleeplessness, diarrhea, nausea, headache and fatigue. No treatment received for the adverse events. Events were considered non serious. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ATENOLOL; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; REMICADE

Current Illness:

ID: 1010649
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling; hot to touch; started lightly at injection site but rash more prominent on sides and back of neck; started lightly at injection site but rash more prominent on sides and back of neck; scratch throat; This is a spontaneous report from a contactable other health professional (patient). A 34-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number and expiration date unknown due to not available/provided to reporter at the time of report completion), via an unspecified route of administration in left arm on 20Jan2021 13:30 at single dose for COVID-19 immunization. The patient's medical history included mild hashimotos (no meds, just monitor) and Polycystic ovarian syndrome (PCOS). No allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Concomitant medications were not reported. It was reported that "48 hours" post injection patient developed neck rash, swelling, hot to touch, started lightly at injection site but rash more prominent on sides and back of neck, and scratch throat. All the events resulted in: emergency room/department or urgent care visit. Therapeutic measures were taken as a result of all the events: Steroid and Benadryl injection. The outcome of the events was recovered with lasting effects. The events was considered as non-serious by reporter, as no resulting in death, no life threatening, no causing/prolonging hospitalization, no disabling/Incapacitating, no congenital anomaly/birth defect. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.?; Sender's Comments: Causality cannot be excluded for PFIZER-BIONTECH COVID-19 VACCINE and the reported events.

Other Meds:

Current Illness:

ID: 1010650
Sex: M
Age:
State: MI

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: After injection, left side finger tips and face tingled. Finger tips resolved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off.; After face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off.; This is a spontaneous report from a contactable consumer reporting for himself. A 47-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number EL3249, via an unspecified route of administration on 22Jan2021 10:00 (at the age of 47-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included acromegaly (surgery done to remove tumor) from an unknown date and unknown. The patient's concomitant medications were not reported. The patient previously took doxycycline and experienced drug allergy. The facility where the most recent COVID-19 vaccine was administered was at a hospital.On 22Jan2021 10:00AM, the patient experienced after injection, left side finger tips and face tingled. Finger tips re-solved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off. The events after injection, left side finger tips and face tingled. Finger tips re-solved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off were reported as non-serious and did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the events. The clinical outcomes of the "after injection, left side finger tips and face tingled. Finger tips resolved, face felt numb afterwards including head and neck. Feels like patient had dental work and the numbing is wearing off" was not recovered. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1010651
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Covid; Test Result: Positive ; Comments: 2 weeks later tested positive for covid

Allergies:

Symptoms: tested Covid19 positive; tested Covid19 positive; This is a spontaneous report from a contactable pharmacist (patient). A 38-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 or 06Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the first dose of vaccine on 05Jan2021 or 06Jan2021 and then 2 weeks later tested positive for COVID in Jan2021. The patient asked how long he was supposed to wait for the second dose. It was just a mild case and he has already recovered the few days in Jan2021. Information on the Lot/Batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be excluded for "tested Covid19 positive".

Other Meds:

Current Illness:

ID: 1010652
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she had the virus last year; she had the virus last year; This is a spontaneous report from a non-contactable consumer, the patient, via the Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (at an unspecified age) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2020 (reported as last year), the patient "had the virus". It was not confirmed if the patient received the 1st dose of the vaccination prior to or after having the virus. The patient queried if she should continue to receive the 2nd dose. The clinical outcome of "had the virus" was unknown. No follow-up attempts are possible; Information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1010653
Sex: F
Age:
State: AZ

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm at vaccination site; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received bnt162b2 (BNT162B2), lot number: EL1283, via an unspecified route of administration Left arm from 23Jan2021 14:15 to 23Jan2021 14:15 at SINGLE DOSE (first dose) for COVID-19 immunisation. Medical history included asthma and penicillin allergy. Concomitant medication included montelukast sodium 10 mg tab, fluticasone propionate, salmeterol xinafoate (ADVAIR), albuterol [SALBUTAMOL]. The patient experienced sore arm at vaccination site on 23Jan2021 15:00 with outcome of recovering. The patient is not pregnant at the time of vaccination. No treatment was received for the event.

Other Meds: MONTELUKAST SODIUM; ADVAIR; ALBUTEROL [SALBUTAMOL]

Current Illness:

ID: 1010654
Sex: F
Age:
State: CO

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever, nausea, dizziness, muscle aches; Fever, nausea, dizziness, muscle aches; Fever, nausea, dizziness, muscle aches; Fever, nausea, dizziness, muscle aches; This is a spontaneous report from a contactable other hcp, the patient. This 49-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EL3302), second dose, via an unspecified route of administration in the right arm on 23Jan2021 at 18:30 (at the age of 49-years-old) as a single dose for COVID-19 vaccination. Medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing, penicillin allergy from an unknown date and unknown if ongoing (Penicillin type antibiotics) and a shellfish allergy from an unknown date and unknown if ongoing. Concomitant medications included omeprazole (OMEPRAZOLE), montelukast sodium (SINGULAIR), fluticasone propionate, salmeterol xinafoate (ADVAIR), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), calcium (CALCIUM) and probiotics (PROBIOTICS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number: EK9231), dose #1, intramuscularly on 02Jan2021 at 0830 in the left arm as a single dose for COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. On 23Jan2021 at 11:00, the patient experienced fever, nausea, dizziness and muscle aches. No therapeutic measures were taken as a result of the events. The clinical outcome of the fever, nausea, dizziness and muscle aches was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: OMEPRAZOLE; SINGULAIR; ADVAIR; VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN C [ASCORBIC ACID]; CALCIUM; PROBIOTICS

Current Illness:

ID: 1010655
Sex: F
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Name: blood work; Result Unstructured Data: Test Result:normal

Allergies:

Symptoms: Muscle and Joint pain for 16 days; Muscle and Joint pain for 16 days; This is a spontaneous report from a contactable other hcp, the patient. This 50-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: EL1284), dose number 2, via an unspecified route of administration in the right arm on 07Jan2021 (at the age of 50-years-old) as a single dose for COVID-19 vaccination. The patient's medical history included Hashimoto's disease from an unknown date and unknown if ongoing and migraines from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (lot number: EK5730), dose #1, intramuscularly in the left arm on 17Dec2020 at 1300 as a single dose for COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. Concomitant medication included ibuprofen (IBUPROFEN). On 08Jan2021 at 0500, the patient experienced muscle and joint pain lasting 16 days. The events resulted in a doctor or other healthcare professional office/clinic visit. The patient also spoke with the physician and blood work was done. All results were normal. Unspecified therapeutic measures were taken as a result of the events. The patient underwent lab tests and procedures which included blood work (Unknown date): results were normal. The clinical outcomes of the muscle and joint pain were resolving. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: IBUPROFEN

Current Illness:

ID: 1010656
Sex: F
Age:
State: MD

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: heavy sweat; night of shot arm hurt so bad I could not sleep, arm still sore; night of shot arm hurt so bad I could not sleep; achy; chills; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration on 19Jan2021 10:30 AM at single dose for COVID-19 immunisation. Vaccine location was Left arm. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Patient was allergies to penicillin, keflex lisinopril and Spiriva Respimat. Other medical history included asthma and heart electrical problem. Concomitant medications the patient received within 2 weeks of vaccination included many for asthma and heart etc. Patient administered the most recent COVID-19 vaccine at Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced shot arm hurt so bad and she could not sleep became achy and chills in the night of 19Jan2021, slept deeply Wed (20Jan2021) and Thursday (21Jan2021) nights. The patient experienced heavy sweat in the night of 21Jan2021 (Thursday) bedclothes very wet in morning Friday (22Jan2021) feel better but arm still sore. Patient was not received treatment for the adverse events. The outcome of events reported as recovering. All events reported as non-serious: adverse event resulted in none of seriousness criteria.

Other Meds:

Current Illness:

ID: 1010657
Sex: F
Age:
State: TX

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Muscle pain; fatigue; fever; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 22Jan2021 at 11:00 (at the age of 54-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC) from an unknown date for an unknown indication. The patient previously received amlodipine and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Jan2021 at 13:30, the patient experienced muscle pain, fatigue, and fever. The patient did not receive any treatment for the events. The clinical outcomes of the muscle pain, fatigue, and fever was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1010658
Sex: M
Age:
State: MT

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; aches; tiredness; This is a spontaneous report from a contactable consumer (patient). A 83-years-old male patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9261) , via an unspecified route of administration on 21Jan2021 18:30 at SINGLE DOSE at left arm for covid-19 immunisation . The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced nausea, aches, tiredness on 22Jan2021 17:30. No treatment for the events. The outcome of events was recovering. No other vaccine in four weeks; No covid prior vaccination; No covid tested post vaccination

Other Meds:

Current Illness:

ID: 1010659
Sex: F
Age:
State: NJ

Vax Date: 01/19/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: body temperature; Result Unstructured Data: Test Result:99-100 Fahrenheit; Comments: about 99-100

Allergies:

Symptoms: fatigue; chills; fever (about 99-100F); the site of injection is sore; a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch!; a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch!; a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch!; This is a spontaneous report from a contactable other health professional reported for herself. This 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK9031) via an unspecified route of administration on 19Jan2021 at 09:15 AM at single dose in left arm for COVID-19 immunization. The patient is not pregnant. Medical history and concomitant medications were reported as none. Allergies to medications, food, or other products was reported as none. The patient previously received the first dose of BNT162B2 (Lot number EH9899) on 30Dec2020 at 11:15 AM at single dose in left arm for COVID-19 immunisation and had no symptoms; Influenza vaccine on 10Dec2020 for immunization. The patient experienced fatigue, chills followed by fever (about 99-100F) lasted for about one and half days. The site of injection is sore even after 3 days. The patient observed a moving painful lump near left shoulder blade (may be supraclavicular lymph nodes), which is warm to touch. The events onset date was reported as 21Jan2021. The events were reported as non-serious. The patient was not diagnosed with COVID-19 Prior to vaccination and not tested for COVID-19 since the vaccination. The patient received no treatment. The outcome of the events was not resolved.

Other Meds:

Current Illness:

ID: 1010660
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (reported as "Age: 46; Unit: Unknown") received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if it was normal to have swollen lymph nodes after getting the 1st dose of the COVID 19 vaccine. The outcome of event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010661
Sex: F
Age:
State: OR

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: burn-like lesion on top of right foot/started as a welt/looks like a blistered burn; sensation of low-grade current flowing through hands and sporadically throughout limbs; This is a spontaneous report from a contactable consumer reporting for herself. A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL1283/expiration date: not provided), via an unspecified route of administration, on 21Jan2021 at 14:45 (at the age of 33 years old) as a single dose in the right arm for COVID-19 IMMUNIZATION. Relevant medical history included latex allergy and allergy to some white cheeses. Concomitant medication was not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Jan2021, the patient experienced sensation of low-grade current flowing through hands and sporadically throughout limbs, mostly for 2hrs following the shot, then occasionally afterward. On 21Jan2021 at 22:45 the patient experienced a burn like lesion on top of right foot, which started as a welt approximately 8 hours after the shot. By morning of second day after shot (23Jan2021), it looks like a blistered burn the size of a dime. The patient did not receive any treatment for these events. The outcome of the events sensation of low-grade current flowing and burn-like lesion on top of right foot/started as a welt/looks like a blistered burn was not recovered. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1010662
Sex: F
Age:
State: MO

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: COVID-19 Blood test; Test Result: Negative ; Test Date: 20210113; Test Name: Body temperature; Result Unstructured Data: Test Result:99.5 to 100.5 Fahrenheit

Allergies:

Symptoms: Temp between 99.5 to 100.5 degrees Fahrenheit; Achy; Headache; Injection site pain; Difficulty lifting arm; stiff neck; Feeling of having the flu; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL8982/expiration date: not provided), via intramuscular route of administration, on 13Jan2021 at 09:15 AM (at the age of 42 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history included gastritis, and COVID-19. The patient had known allergies to Bactrim. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication included omeprazole 20mg daily, cetirizine hydrochloride (ZYRTEC) 10mg daily, vitamin D3 200 IU daily, and bifidobacterium bifidum, bifidobacterium lactis, lactobacillus acidophilus, lactobacillus brevis, lactobacillus bulgaricus, lactobacillus casei, lactobacillus paracasei, lactobacillus plantarum, lactobacillus rhamnosus, lactobacillus salivarius (PROBIOTIC 10) 20 billion live probiotic cultures. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Jan2021 at 10:30 PM, the patient experienced temperature between 99.5 to 100.5 degrees Fahrenheit, achy, headache, injection site pain and difficulty lifting arm, stiff neck and feeling of having the flu. All symptoms lasting 48 hours. The events were reported as non-serious. The patient did not receive any treatment for these events. The outcome of the events temperature between 99.5 to 100.5 degrees Fahrenheit, achy, headache, injection site pain and difficulty lifting arm, stiff neck and feeling of having the flu was recovered on an unspecified date in Jan2021. Since the vaccination, the patient had been tested for COVID-19 which included a blood test on 21Jan2021 which was negative.

Other Meds: OMEPRAZOLE; ZYRTEC; VITAMIN D3; PROBIOTIC 10

Current Illness:

ID: 1010663
Sex: F
Age:
State: MI

Vax Date: 01/09/2021
Onset Date: 01/14/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen glands; severe headache; muscle pain; extremely tired; body hurts; This is a spontaneous report from a contactable consumer (patient). This 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number El3248/expiration date: unknown), via unknown route of administration, on 09Jan2021 12:30 PM (at the age of 60 years old) as a single dose on left arm for COVID-19 immunisation for COVID-19 immunisation at a Public Health Clinic/Veterans Administration facility. Relevant medical history included breast cancer last year. The patient had no allergies to medications, food or other products. Relevant concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. It was reported that the patient experienced swollen glands, severe headache, muscle pain, extremely tired, body hurts on 14Jan2021. The outcome of the events swollen glands, severe headache, muscle pain, extremely tired, body hurts was not recovered. No treatment was received for the events. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1010664
Sex: F
Age:
State: NC

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itch at site; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3247) via an unspecified route of administration in the right arm on 20Jan2021 10:45 AM at a single dose as COVID-19 vaccine. Medical history included allergies to maybe penicillin. Concomitant medications (received within 2 weeks of vaccination) included trazodone, fluticasone propionate (FLONASE), and cetirizine hydrochloride (ZYRTEC). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced itch at site on 22Jan2021 12:00 PM. Treatment was not received for the event. The event was non-serious in which did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. She has not been tested for COVID-19 since the vaccination. The outcome of the event was not recovered.

Other Meds: TRAZODONE; FLONASE [FLUTICASONE PROPIONATE]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1010665
Sex: M
Age:
State: AR

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tongue began to swell; had a tingling feeling in chest and abdomen; Slightly sore arm; This is a spontaneous report from a contactable consumer. A 96-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number: EL898), via an unspecified route of administration on the right arm on 16Jan2021 12:30 at SINGLE DOSE for COVID-19 immunization at the pharmacy or drug store. Medical history included hypertension, glaucoma, benign prostatic hyperplasia (BPH), skin cancer, gout, and malaria (three times experienced). The patient had also allergies with wasp stings which later manifested of anaphylactic. Patient had unspecified concomitant medications. The patient received vaccine on 16Jan2021 at approximately 12:30 pm. Within 5 minutes (12:35), the tongue began to swell, and patient had a tingling feeling in chest and abdomen. The patient also had slightly sore arm. The patient drove towards emergency room (ER) but within 20 minutes the symptoms had subsided enough to not go to ER and head home. The patient was not diagnosed with COVID-19 prior and since vaccination. No treatment was received for the events. Symptoms disappeared on unknown date in Jan2021 and never recurred.

Other Meds:

Current Illness:

ID: 1010666
Sex: F
Age:
State: OH

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vertigo (strong) about 2 hours after receiving shot; This is a spontaneous report from a contactable consumer (patient). An 89-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) 0n 21Jan2021 at 16:15 at single dose via an unspecified route of administration on left arm for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On 21Jan2021 about 2 hours after receiving shot the patient experienced vertigo (strong). Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1010667
Sex: F
Age:
State: GA

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hard time breathing; Rash all over body; This is a spontaneous report from a contactable pharmacist. A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El3249), intramuscular at arm left on 24Jan2021 at 13:30 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 24Jan2021 at 13:30, the patient experienced rash all over body and hard time breathing. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with BENADRYL and EPIPEN. The patient outcome of the events was recovering.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events dyspnea and rash cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1010668
Sex: F
Age:
State: MI

Vax Date: 01/18/2021
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 202003; Test Name: tested for Covid; Test Result: Negative ; Comments: After that I took a Covid test in March and in March it was negative.; Test Date: 202008; Test Name: tested for Covid; Test Result: Negative ; Comments: Then I took another one in August and it was negative.

Allergies:

Symptoms: Caller wanted to know if the vaccine would cause a strange odor in her nose/I have an odd odor that I continue to smell in my nose; This is a spontaneous report from a contactable consumer (patient). This 76-years-old female patient received the first dose of BNT162B2 (the covid 19 vaccine Batch/lot number: EL3249) on 18Jan2021 at single dose for covid-19 immunization. Medical history was Diabetic, High Blood pressure, Pain, Heart burn. On 04Jan2020, patient stated became quite ill and that was before COVID was made public. So I thought I had flu but I was sick about for two and a half weeks that I did not get out of bed, could barely move. I couldn't eat, I lose a lot of weight, I lost my sense of smell and taste. I think now I may have COVID. I am getting a smell that is very unusual and it's hard to describe, it's kind of a pungent kind of a smell. I can't really describe it, correct and is there any remedy for it After that I took a COVID test in March and in March it was negative. Then I took another one in August and it was negative. Concomitant drug included Metformin for Diabetic, Lisinopril for High Blood pressure, Tramadol for pain. Patient had a strange odor in her nose from 19Jan2021/20Jan2021, continue to smell in her nose. Outcome of the event was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: METFORMIN; LISINOPRIL; TRAMADOL

Current Illness:

ID: 1010669
Sex: F
Age:
State: CA

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Loss of taste; This is a spontaneous report from a contactable health professional, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular in the right arm on 22Jan2021 at 15:45 (at the age of 42-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported; however, it was reported that the patient received other unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. On 23Jan2021 at 09:00, the patient experienced loss of taste. The patient was not treated for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of loss of taste was resolving. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010670
Sex: F
Age:
State:

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on inside of elbow on same arm as injection; This is a spontaneous report from a non-contactable consumer report for self. This 27-year-old not pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration at arm on 20Jan2021 16:00 at single dose for COVID-19 immunization. The patient's medical history and patient's concomitant medications were not reported. The patient experienced rash on inside of elbow on same arm as injection on 22Jan2021. Event recovered on 24Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1010671
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness at site of injection the following morning; This is a spontaneous report from a non-contactable consumer. An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced soreness at site of injection the following morning on an unspecified date. The event was reported as non-serious. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1010672
Sex: M
Age:
State: MO

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I had some pain around the shot area; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Jan2021 at 14:30 at single dose in left arm for COVID-19 immunisation at the age of 78-year-old. Lot number was EL3302. The medical history and the concomitant medications were not reported. The patient had some pain around the shot area on 19Jan2021 at 17:30 and he took TYLENOL, 2 tablets 500 mg each within 4 hours of receiving the shot. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the event.

Other Meds:

Current Illness:

ID: 1010673
Sex: M
Age:
State: NY

Vax Date: 01/05/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Erectile Dysfunction; This is a spontaneous report from a contactable Other HCP. A 47-year-old male Other HCP reported that he received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), intramuscular at single dose into the right arm on 05Jan2021 09:30 AM for COVID-19 immunization. Medical history included kidney stones. Concomitant drugs were unknown. The patient reported that on 20Jan2021 he experienced erectile dysfunction. No treatment was received. The outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: As an individual case report there is not enough evidence to establish a causal relationship with the suspect vaccine. Currently there is no clear biological plausibility between the vaccine use and the even onset. More information such as complete medical history and concomitant medications are needed for fully medical assessment. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1010674
Sex: F
Age:
State: PA

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210101; Test Name: tested for covid; Result Unstructured Data: Test Result:tested positive for covid

Allergies:

Symptoms: First vaccine 31Dec, tested positive for covid 01Jan; First vaccine 31Dec, tested positive for covid 01Jan; This is a spontaneous report from a contactable Other HCP. This Other HCP reported for self that the 21-year-old female patient received first dose of bnt162b2 (BNT162B2, COVID 19, Pfizer), via an unspecified route of administration on 31Dec2020 02:30 PM on Right arm at single dose for covid-19 immunisation. Medical history included known allergies: Cefdinir, asthma, anxiety, and depression. Concomitant medications included Duloxetine, lamotrigine, buspirone hydrochloride (BUSPAR), etonogestrel (NEXPLANON), ethinylestradiol/ norethisterone acetate (JUNEL). First vaccine 31Dec2020, tested positive for covid 01Jan2021, had second dose 21Jan2021. The outcome of the events was unknown. Information on the Lot/Batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.

Other Meds: DULOXETINE; LAMOTRIGINE; BUSPAR; NEXPLANON; JUNEL

Current Illness:

ID: 1010675
Sex: F
Age:
State: WA

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizziness; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 19-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL1284) via an unspecified route of administration in the left arm on 20Jan2021 at a single dose as Covid vaccine. There were no medical history and no concomitant medications (no other vaccine in four weeks and no other medications in two weeks). The patient experienced dizziness on an unspecified date. The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1010676
Sex: F
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swelling on the left side of her jaw and throat began to swell/swelling on left side of face and throat; Tingling; swelling on the left side of her jaw and throat began to swell/swelling on left side of face and throat/whelping up on the left side of jaw; felt a funny sensation in her throat and face/still not feeling herself; soreness; left arm was sore; throat still feels funny; feels scratchy; feeling fatigued; This is a spontaneous report from a contactable consumer reporting for herself. A 45-years-old female patient started to receive bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) (lot# EH9899, exp date 31Mar2021), via an unspecified route of administration in the left arm, on 15Jan2021 at 14:30, at single dose, for COVID-19 immunisation. Medical history and concomitant medications were none. The patient experienced left arm was sore on 16Jan2021 with outcome of recovered, swelling on the left side of her jaw and throat began to swell/swelling on left side of face and throat on 18Jan2021 with outcome of recovering, tingling on 18Jan2021 with outcome of recovering, swelling on the left side of her jaw and throat began to swell/swelling on left side of face and throat/whelping up on the left side of jaw on 18Jan2021 with outcome of recovering, felt a funny sensation in her throat and face/still not feeling herself on 18Jan2021 with outcome of not recovered, feeling fatigued in Jan2021 with outcome of not recovered, soreness on 16Jan2021 with outcome of recovering, throat still feels funny; feels scratchy on Jan2021 with outcome of not recovered. The patient visited the emergency room for left arm was sore, swelling on the left side of her jaw and throat began to swell/swelling on left side of face and throat, tingling, swelling on the left side of her jaw and throat began to swell/swelling on left side of face and throat/whelping up on the left side of jaw. The patient was treated in the emergency room with prednisone, Benadryl and acid medicine for her stomach.

Other Meds:

Current Illness:

ID: 1010677
Sex: F
Age:
State: OR

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe swelling surrounding injection site; hot to touch surrounding injection site; This is a spontaneous report from a contactable 42-year-old female Health care professional who reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Fck9231) intramuscular at single dose for COVID-19 immunisation on 11Jan2021 at 12:00 pm. Relevant history included allergy with sulfa. Relevant concomitant drugs included lamotrigine (LAMICTAL), propranolol. The patient was not pregnant at the time of vaccination. The patient experienced severe swelling, hot to touch surrounding injection site since 11Jan2021 at 13:00. Symptoms remained for 11 days after administration. No treatment was received. The outcome of events was resolving. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19. Since the vaccination, the patient had not test for COVID-19.

Other Meds: LAMICTAL; PROPRANOLOL

Current Illness:

ID: 1010678
Sex: F
Age:
State: TX

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: En5318; Expiration date was not reported) on 22Jan2021 (10:45) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization. Medical history included multiple (MS), blood clots and pulmonary embolism. Concomitant medications included rivaroxaban (XARELTO) and omeprazole. The patient previously took clarithromycin (BIAXIN), and had drug allergies. The patient was not pregnant at the time of vaccination. On 23Jan2021 (16:00), the patient had nausea. The patient did not receive any treatment for the event, nausea. The outcome of the event, nausea, was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination, and was not tested post-vaccination.

Other Meds: XARELTO; OMEPRAZOLE

Current Illness:

ID: 1010679
Sex: F
Age:
State: IL

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Extreme fatigue; Chills; This is a spontaneous report from a contactable consumer (patient). A 88-year-old female patient started received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, lot/batch number: EL3247), via an unspecified route of administration on the right arm on 19Jan2021 13:30 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history included haemolytic anaemia, diabetes, had spleen removed (splenectomy) on an unknown date, breast cancer. The patient had allergies with cats, lisinopril, and furosemide. The patient was not pregnant (including at the time of vaccination). Concomitant medications included metformin (METFORMIN), insulin glargine (LANTUS), atorvastatin (ATORVASTATIN), and warfarin (WARFARIN). It was reported that the patient had chills and extreme fatigue from time of vaccination on 19Jan2021 14:30, all the way through the next day of 20Jan2021. The patient just went take a nap from 4:00 to 5:30 PM on 20Jan21 then slept through the alarm until 7:45 PM. The patient was not diagnosed with COVID-19 prior and since vaccination. The patient recovered from the events in Jan2021.

Other Meds: METFORMIN; LANTUS; ATORVASTATIN; WARFARIN

Current Illness:

ID: 1010680
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/18/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: Covid 19; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: Diagnosed with Covid 19; Diagnosed with Covid 19; This is a spontaneous report from a contactable Nurse reported for herself. A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021 at single dose for COVID-19 immunization. Medical history and Concomitant medications were not reported. She was diagnosed with Covid 19 on 18Jan2021. She was supposed to get second dose on 26Jan2021. The outcome of the events was unknown. Information about batch number was not available and is going to be requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.

Other Meds:

Current Illness:

ID: 1010681
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash going down her arms; This is a spontaneous report from a contactable consumer. A 26-year-old female patient received bnt162b2 (BNT162B2), lot number not reported, via an unspecified route of administration from an unspecified date to an unspecified date at SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced rash going down her arms on an unspecified date with outcome of unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010682
Sex: F
Age:
State: TX

Vax Date: 01/09/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bell's Palsy; progressed to left facial drooping; loss of taste on anterior part of tongue; decreased tear production in my left eye; started with left neck pain; This is a spontaneous report from a contactable other health care professional (HCP) (patient). A 23-year-old female patient not pregnant received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration Left arm on 09Jan2021 at 04:30 PM as a single dose for COVID-19 immunisation, lot number: EL1283. Medical history was reported as none. Concomitant medications in two weeks prior to the vaccination included oral contraceptive pill (OCPs). Patient received first vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 19Dec2020 at 04:00 PM at Left arm for COVID-19 immunisation, lot number: EK5730. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 22Jan2021 03:00 PM (Symptom onset was 2 weeks after second vaccine) patient initially started to experience left neck pain, and then progressed to left facial drooping, loss of taste on anterior part of tongue, and decreased tear production in her left eye. Presentation consistent with Bell's Palsy. Patient started a course of methylprednisolone the day of the report with no improvement yet. Events resulted in Doctor or other healthcare professional office/clinic visit. Patient had no COVID prior vaccination. Patient was not tested for Covid post vaccination. Patient had not recovered from the events, at the time of the report.; Sender's Comments: The events left neck pain, and then progressed to left facial drooping, loss of taste on anterior part of tongue, and decreased tear production in her left eye are considered possibly related to the suspect product based on temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1010683
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm pain; This is a spontaneous report from a contactable Health Professional. A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 13Jan2021 (at the age of 61-years) as a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced arm pain from vaccination on an unspecified date. The clinical outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1010684
Sex: F
Age:
State: FL

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; throwing up bile; no appetite; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received BNT162B2, via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunization. Medical history included hypertension. No COVID prior vaccination. Concomitant medications included azilsartan kamedoxomil (EDARBI), troxipide (PRESTONE), and torsemide (TORSEMIDE). The patient previously took erythromycin and experienced drug allergy. Patient experienced nausea and throwing up bile, no appetite on 21Jan2021. No treatment received for these events. No COVID tested post vaccination. Outcome of the events was not resolved. Information on the lot/batch number has been requested.

Other Meds: EDARBI; PRESTONE; TORSEMIDE

Current Illness:

ID: 1010685
Sex: F
Age:
State: CT

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: flushed in the face/warm; red face; tingling sensation of lips but no swelling; mild allergic reaction; This is a spontaneous report from contactable consumers. An 88-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), via an unspecified route of administration on 20Jan2021 11:45 at single dose (left arm) for COVID-19 immunization. Medical history included lung cancer. The patient was not pregnant. Concomitant medications were not reported. It was reported that the patient had unspecified other medication in two weeks. The reporter's mother's experienced mild allergic reaction in Jan2021 and she wants to know whether or not she should be getting her second dose. She will be asking her doctor as well as they were advised by the nurse administering the vaccine and also the doctor's nurses who observed her mother afterwards, but she was also advised to contact Pfizer. On 20Jan2021, at 12:00, within 5 minutes, the patient experienced flushed in the face/warm, red face, tingling sensation of lips but no swelling, no increased blood pressure, no hives or rash, no tongue or throat swelling, no dizziness, no nausea. It was mild but concerning. The patient was treated with oral Benadryl and Pepcid IV (also reported as IV of peptids), and extended observation for 1 hour and 30 minutes. The events resulted in doctor or other healthcare professional office/clinic visit. The patient had no Covid prior vaccination and was not Covid tested post vaccination. The consumer would like to know if her mother was safe to receive the second dose of the Covid vaccine and if the reaction to the second dose of the Covid vaccine will be more severe with a history of an allergic reaction to the first dose. Outcome of event mild allergic reaction was unknown; outcome of the rest of events was recovered in Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010686
Sex: F
Age:
State:

Vax Date: 11/16/2020
Onset Date: 01/19/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tiredness; This is a spontaneous report from a contactable consumer (patient), based on the information received by Pfizer from (manufacturer control number: EC-2020-084563), for BNT162B2. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at single dose for covid, lenvatinib mesilate (LENVIMA), via an unspecified route of administration from 16Nov2020 to an unspecified date at 12 mg, daily for hepatocellular carcinoma (HCC) C22. The patient's medical history included headache. Concomitant medications were not reported. Patient reported headache and some tiredness since taking lenvatinib mesilate but also thought that her tiredness was attributed to her receiving COVID vaccine. The patient experienced tiredness on 19Jan2021 with outcome of unknown. Action taken for lenvatinib mesylate was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1010687
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness at the injection site; This is a spontaneous report from a contactable consumer (patient is reporter's mother). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced soreness at the injection site on an unspecified date with outcome of unknown. The reporter learned the evening of Jan21. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1010688
Sex: F
Age:
State: GA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: face got even hotter/her face felt warm; mild allergic reaction; scalp itchiness moved to the back of her neck down the middle of her back; eyes started to itch; arm soreness/it felt like a bruise; arm soreness/it felt like a bruise; This is a spontaneous report from a contactable consumer(patient). The 67-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3246), via an unspecified route of administration in the right arm on 20Jan2021 14:05 at single dose for COVID-19 immunization. Medical history included gastrooesophageal reflux disease (GERD), hot flashes, Cholesterol, clear her lungs, eyes(disorder), hair(disorder), high cholesterol, heart(disorder), arthritis in hip and knee, face felt warm from 2015, quit smoking, back pain. In 2015 she had a reaction to a cortisone shot in her knee and experienced her face felt warm. She got a spinal epidural last Jan2020, she had gone to an allergist prior to the spinal epidural to take a five hour test for allergy to dexamethasone and had a very mild reaction with face warming so she did get the spinal. When she got a flu shot her arm would be sore when she moved it. Her last flu shot(Infs Fluarix Quadrivalent) was on 24Sep2020 at his 67-year-old. she usually didn't have issues with vaccines but she was going to make herself wait the 30 minutes due to her weird reactions. She had a lot of weird reactions to medications and always had to wait 30 minutes for Penicillin and sulfa. Penicillin put her in a coma for two days when she was 7 years old. She has never had penicillin since then. with Sulfa she got an immediate rash and itching but that was 20 years ago. She couldn't take pain killers and lots of other medications including clindamycin; Neurontin; gabapentin; carbamazepine; endocet; metoprolol; tamalor. The pain medication issue happened in 2003 and the metoprolol issue happened in 2008. Ongoing concomitant medication included aloe vera for hot flashes and GERD, acetylsalicylic acid (ASPIRIN) for high cholesterol and heart, biotin for hair, cod liver oil to clear her lungs(like a heart supplement), famotidine for GERD, chondroitin sulfate sodium/glucosamine (GLUCOSAMINE AND CHONDROITIN) for arthritis in hip and knee, lansoprazole for GERD, latanoprost for eyes, lovastatin for blood cholesterol, xantofyl (LUTEIN) for eyes , zeaxanthin from 21Jan2021 for eyes and multivitamins(women over 50) for supplement. On 20Jan2021, the patient experienced a mild allergic reaction to the vaccine, only had a mild reaction, she had a mask on and when she got in the car and took off the mask, her face felt warm; Her reaction(face getting warm) was similar to what she experiences with a cortisone shot and dexamethasone before. The face feeling warm happened about 35 minutes after the vaccine(20Jan2021 14:40), then she got home and her face got even hotter; her scalp started to itch, it was really itchy; her eyes started to itch and then the scalp itchiness moved to the back of her neck down the middle of her back for about 2 hours. All of the itchiness went away after about three hours or 17:00PM on 20Jan2021; then a little bit of the scalp itching came back for about 45 minutes and then went away. All of the itching has been gone since evening on 20Jan2021. Later that night on 20Jan2021, she noticed she had a little bit of arm soreness; it felt like a bruise; when she laid on it hurt. 21Jan2021 it had gone away, too. The arm soreness wasn't even as bad as the flu shot. She was scheduled to receive the second dose of the Pfizer COVID 19 vaccine 10Feb2021. Outcome of arm soreness/it felt like a bruise was recovered in 21Jan2021, of other events was recovered on 20Jan2021.

Other Meds: ALOE VERA; ASPIRIN [ACETYLSALICYLIC ACID]; BIOTIN; COD LIVER OIL; FAMOTIDINE; GLUCOSAMINE AND CHONDROITIN; LANSOPRAZOLE; LATANOPROST; LOVASTATIN; LUTEIN; ZEAXANTHIN

Current Illness:

ID: 1010689
Sex: M
Age:
State: GA

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: Creatinine; Result Unstructured Data: Test Result:1.91; Test Date: 20210118; Test Name: blood sugar; Result Unstructured Data: Test Result:116; Test Date: 20210118; Test Name: BUN; Result Unstructured Data: Test Result:43; Test Date: 20210118; Test Name: comprehensive biochemical; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: swelling of right arm, where he received the vaccine; Palpable purpura/Some of the purpura was on the left arm and he had a few spots on the upper chest; Blistering; This is a spontaneous report from a contactable physician. An 88-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at right arm on 09Jan2021 at single dose for COVID-19 vaccination (reported as for "1-B vaccine group, age greater than 75, history of heart disease") in hospital. Co-suspect drug included apixaban (ELIQUIS) orally from 2020 (Has been on Eliquis for over the last year, 12 months) and ongoing at 5 mg, 2 times a day (5mg, 1 tablet by mouth twice daily) for heart failure and atrial fib. Medical history included heart failure, atrial fib. Concomitant medication was not reported. No other vaccines given the same day or 4 weeks prior. Mentions patient did have a flu shot back in Sep2020 (unable to provide NDC, Lot, or expiry), no problems with vaccines in past. Patient received the first dose Saturday morning of 09Jan2021 with no ill effects. 3-4 days later (Jan2021) patient had swelling of right arm, where he received the vaccine, and then developed palpable purpura. Some of the purpura was on the left arm and he had a few spots on the upper chest. Had no fever, no malaise, just what the patient described as blistering and so they had a dermatologist look at it. All seems to be improving. They were curious as to what this is. The patient feels fine and is ambulatory and the purpura does not itch. Caller does not provide seriousness criteria when queried. Initially it was thought, because the patient was on Eliquis for heart failure and atrial fib, that the Eliquis was related to events, but when the Dermatologist looked at it and stated it maybe excavation they decided to call and find out what Pfizer wanted them to do. Caller states he can give a list of medications if needed. Says patient had a comprehensive biochemical profile done non fasting also on 18Jan2021. Patient was seen by him initially on 19Jan2021. Wants to know whether this is a safety concern or/and if the patient should have the second dose. event requires a visit to physician office. Lab test on 18Jan2021 included Comprehensive Biochemical Profile, Blood Sugar of 116, Creatinine of 1.91, BUN of 43. Action taken of apixaban was dose not changed. Patient was recovering from the events. Relatedness of drug to event swelling of right arm, Palpable purpura and Blistering, feels fine, ambulatory, no fever, no malaise, seen by dermatologist, purpura does not itch, on Eliquis. Per Source of assessment (Primary Source Reporter) and Method of assessment (Global Introspection) for drug result (Covid-19 vaccine) was Related, of drug result (Eliquis) was unrelated. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1010690
Sex: F
Age:
State: NY

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Passed out; fell; became disoriented and weak; became disoriented and weak; could not control her body, all muscles felt heavy and weak; could not control her body, all muscles felt heavy and weak; Felt tingles in feet and lower legs; This is a spontaneous report from a contactable consumer(patient). The 28-year-old female patient(not pregnant) received first dose BNT162B2(COVID 19, lot number: EL9262), via an unspecified route of administration at left arm on 22Jan2021 13:00 at single dose for COVID-19 immunization. Medical history included none. She had no known allergies. Concomitant medication included spironolactone, amfetamine aspartate/amfetamine sulfate/ dexamfetamine saccharate/ dexamfetamine sulfate (ADDERALL), vitamin b complex (VITAMIN B), ergocalciferol (VIT D), ZINC, omeg(omeprazole). There was no other vaccine in four weeks. About 11 hours after receiving(23Jan2021), she very quickly became disoriented and weak, could not control her body, all muscles felt heavy and weak. She fell once and then presumably passed out - she came to after falling again. She felt tingles in feet and lower legs. After sleeping about 9 hours, she felt better. There was no treatment received, no covid prior vaccination, covid tested post vaccination. Events were assessed as non-serious. Outcome of events was recovering.

Other Meds: SPIRONOLACTONE; ADDERALL; VITAMIN B; VIT D; ZINC; OMEPRAZOLE

Current Illness:

ID: 1010691
Sex: M
Age:
State: CO

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data:

Allergies:

Symptoms: atrial fibrillation; disease recurrence; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), at single dose on 21Jan2021 for COVID-19 immunization. medical history included atrial fibrillation. Concomitant drugs were unknown. the reporting consumer received a message on 23Jan2021 stating that the patient started having atrial fibrillation the night before. The outcome of the event was unknown. Information on batch/lot number was requested.

Other Meds:

Current Illness:

ID: 1010692
Sex: M
Age:
State: LA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: pulse; Result Unstructured Data: Test Result:78; Test Date: 20210115; Test Name: pulse; Result Unstructured Data: Test Result:76; Test Date: 20210115; Test Name: O2; Test Result: 97 %; Test Date: 20210115; Test Name: O2; Test Result: 98 %; Test Date: 20210115; Test Name: respiratory rate; Result Unstructured Data: Test Result:20; Test Date: 20210115; Test Name: respiratory rate; Result Unstructured Data: Test Result:18; Test Date: 20210115; Test Name: vital signs; Result Unstructured Data: Test Result:122/84; Test Date: 20210115; Test Name: vital signs; Result Unstructured Data: Test Result:188/76

Allergies:

Symptoms: tired; not feeling well; nausea; dizziness/almost passed out; This is a spontaneous report from a contactable nurse and a consumer. A 46-year-old male patient received the first dose of BNT162B2 (lot number: EL3247, expiry date: 31May2021), via an unspecified route of administration in left deltoid on 15Jan2021 12:56 at single dose for COVID-19 immunization. Medical history included had allergies as a child and carried as an epi pen. Concomitant medications were not reported. Reported to the waiting area for 15 minutes observation and left then came back to facility at 14:05 was not feeling well, reported dizziness and nausea. RN assessed patient, vital signs 122/84, pulse was 78 and O2 97 on room air, respiratory rate was 20, alert and oriented, was monitored for 30 minutes, reassessed at 14:25 188/76, heart rate 76, respiratory rate 18, O2 sats 98% on room air, encouraged patient to follow up with PCP or ER. Patient walked out with companion and stated he was feeling better. On 18Jan2021, patient was called for follow p, only complained he was as still tired, all other side effects had resolved. Stated he almost passed out upon coming back to the observation unit on 15Jan2021. Reporter stated it was noted that when patient returned for 2nd dose, would monitor for 45 minutes. Outcome of the event tired was not resolved, of event not feeling well was unknown, and of other events was resolved.

Other Meds:

Current Illness:

ID: 1010693
Sex: U
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: testing postive for COVID; Test Result: Positive

Allergies:

Symptoms: testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 2nd of 14 reports. An elderly patient (more than 65 years) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021 with outcome of unknown. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab. The event resulted in doctor or other healthcare professional office/clinic visit. Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-2021063794 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 1010694
Sex: U
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: COVID; Test Result: Positive

Allergies:

Symptoms: testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is 3rd of 14 reports. An elderly patient (more than 65 years) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021 with outcome of unknown. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab. The event resulted in doctor or other healthcare professional office/clinic visit. Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-2021063794 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 1010695
Sex: U
Age:
State: VA

Vax Date: 01/13/2021
Onset Date: 01/21/2021
Rec V Date: 02/08/2021
Hospital:

Lab Data: Test Date: 20210121; Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar event for 14 patients. This is the 4th of 14 reports. An elderly patient (more than 65 years old) of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab. The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded. ,Linked Report(s) : US-PFIZER INC-2021063794 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm